ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial-mesenchymal transition by β-catenin and Beclin1/autophagy signaling in colorectal cancer

Zhu, Yin; Huang, Shimiao; Chen, Shengyuan; Chen, Jiaxuan; Wang, Zhiqing; Wang, Yadong; Zheng, Haoxuan*南方医科大学
Cell Death & Disease2021-5-5DOI: 10.1038/s41419-021-03733-5
67被引11阅读
引用收藏
分享

摘要

Sex-determining region Y-box2 (SOX2), a master regulator of embryonic and induced pluripotent stem cells, drives cancer stem cells (CSCs) properties, fuels tumor initiation, and contributes to tumor aggressiveness. Our previous study has demonstrated the oncogenic role of SOX2 in colorectal cancer (CRC). In this study, we sought to elucidate the underlying mechanisms. Cell function experiments were performed to detect chemoresistance, proliferation, stemness, migration, and invasion in vitro. Chromatin immunoprecipitation, co-immunoprecipitation, luciferase reporter assay, and immunofluorescence were performed to explore the regulation of ABCC2, beta-catenin, and Beclin1 by SOX2. The carcinogenic role of SOX2-beta-catenin/Beclin1-ABCC2 axis in vivo was analyzed by CRC tissues and xenograft models. Here, we reported that SOX2 sustained chemoresistance by transcriptional activation of ABCC2 expression. Suppressing either beta-catenin or autophagy signaling curbed SOX2-driven chemoresistance, stemness, and epithelial-mesenchymal transition (EMT). Mechanistically, SOX2 combined with beta-catenin and increased its nuclear expression and transcriptional activity. Transcriptional activation of Beclin1 expression by SOX2 consequently activating autophagy and inducing malignant phenotype. Furthermore, overexpression of beta-catenin or Beclin1 facilitated ABCC2 expression. The clinical analyses showed that high expression of ABCC2 and Beclin1 were positively correlated with SOX2 and were associated with poor prognosis in CRC patients. Finally, xenograft models revealed that inhibition of SOX2 expression and autophagy restrained tumor growth and chemoresistance in vivo. Conclusively, we demonstrated a novel mechanism by which the SOX2-beta-catenin/Beclin1/autophagy signaling axis regulates chemoresistance, stemness, and EMT in CRC. Our findings provide novel insights into CRC carcinogenesis and may help develop potential therapeutic candidates for CRC.

学科与关键词

关键词
MULTIDRUG-RESISTANCEINITIATING CELLSCHROMOSOME 17QAUTOPHAGYMETASTASISEXPRESSIONPATHWAYACTIVATIONSUPPRESSIONPROGRESSION
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Cell Death & Disease
发表日期
2021-05-05
卷期
第 12 卷, 第 5 期
页码
449
DOI
10.1038/s41419-021-03733-5
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81773191]; National Major New Drug Creation Science and Technology Major Special Fund Funding Project [2020ZX09201017]; Guangdong Gastrointestinal Disease Research Center [2017B020209003]

作者

  • Z

    Zhu, Yin (第一作者)

    southern med univ

  • H

    Huang, Shimiao

    southern med univ

查看全部 7 位作者收起作者
  • C

    Chen, Shengyuan

    southern med univ

  • C

    Chen, Jiaxuan

    southern med univ

  • W

    Wang, Zhiqing

    southern med univ

  • W

    Wang, Yadong

    southern med univ

  • Z

    Zheng, Haoxuan (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417